Assignee
BIOHAVEN PHARM HOLDING CO LTD
US·14 granted patents·8 pending applications·74 citations·filing 2013–2022
Top patents by PatentIndex Score
22 records- 0197US10639298B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2016·Granted May 5, 2020·12 cites·10 claims
- 0297US10485791B2Riluzole prodrugs and their useBIOHAVEN PHARM HOLDING CO LTD·Filed 2016·Granted Nov 26, 2019·18 cites·4 claims
- 0395US10357497B2Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosisBIOHAVEN PHARM HOLDING CO LTD·Filed 2013·Granted Jul 23, 2019·12 cites·4 claims
- 0495US9725427B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2013·Granted Aug 8, 2017·20 cites·11 claims
- 0592US11440893B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Granted Sep 13, 2022·2 cites·5 claims
- 0692US11083724B2Rimegepant for CGRP related disordersBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Granted Aug 10, 2021·4 cites·20 claims
- 0790US10844026B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Granted Nov 24, 2020·2 cites·7 claims
- 0888US10562870B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2017·Granted Feb 18, 2020·2 cites·3 claims
- 0987US11400155B2Use of riluzole, riluzole prodrugs or riluzole analogs with immunotherapies to treat cancersBIOHAVEN PHARM HOLDING CO LTD·Filed 2017·Granted Aug 2, 2022·2 cites·19 claims
- 1082US12172974B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2022·Granted Dec 24, 2024·0 cites·8 claims
- 1176US12343347B2Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosisBIOHAVEN PHARM HOLDING CO LTD·Filed 2021·Granted Jul 1, 2025·0 cites·3 claims
- 1264US12364687B2Use of riluzole oral disintegrating tablets for treating diseasesBIOHAVEN PHARM HOLDING CO LTD·Filed 2019·Granted Jul 22, 2025·0 cites·4 claims
- 1361US12029731B2Acyl benzo[d]thiazol-2-amine and their methods of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2017·Granted Jul 9, 2024·0 cites·3 claims
- 1460US2021000814A1Rimegepant for cgrp related disordersBIOHAVEN PHARM HOLDING CO LTD·Filed 2019·Application pending·0 cites
- 1558US2021196699A1Cgrp antagonists for treating migraine breakthroughBIOHAVEN PHARM HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 1654US2021338654A1Cgrp antagonists for treating migraine breakthroughBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 1751US2023285390A1Methods of treating pulmonary injury with cgrp inhibitorsBIOHAVEN PHARM HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 1850US2022401439A1Intranasal pharmaceutical compositions of cgrp inhibitorsBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 1950US2023108049A1Oral fast-dispersing dosage form of rimegepantBIOHAVEN PHARM HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 2047US2018318268A1Amine prodrugs of pharmaceutical compoundsBIOHAVEN PHARM HOLDING CO LTD·Filed 2016·Application pending·0 cites
- 2141US11358935B2Prodrugs of lanicemine and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2017·Granted Jun 14, 2022·0 cites·32 claims
- 2241US2021023061A1Use of riluzole prodrugs to treat ataxiasBIOHAVEN PHARM HOLDING CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIOHAVEN PHARM HOLDING CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →